Publication: Binding energy analysis for wild-type and Y181C mutant HIV-1 RT/8-Cl TIBO complex structures: Quantum chemical calculations based on the ONIOM method
1
0
Issued Date
2005
Resource Type
File Type
application/pdf
ISSN
8873585
Other identifier(s)
2-s2.0-28644442414
Rights Holder(s)
Scopus
Bibliographic Citation
Proteins: Structure, Function and Genetics. Vol 61, No.4 (2005), p.859-869
Suggested Citation
Saen-Oon S., Kuno H., Hannongbua S. Binding energy analysis for wild-type and Y181C mutant HIV-1 RT/8-Cl TIBO complex structures: Quantum chemical calculations based on the ONIOM method. Proteins: Structure, Function and Genetics. Vol 61, No.4 (2005), p.859-869. doi:10.1002/prot.20690 Retrieved from: https://hdl.handle.net/20.500.14740/6042
Author(s)
Abstract
Two-layered and three-layered ONIOM calculations were performed to compare the binding energies of 8-Cl TIBO inhibitor when bound into the human immunodeficiency virus reverse transcriptase binding pocket and a Y181C variant. Both consisted of 20 residues within a radius of 15 Å. A combination of different methods [HP2/6-31G(d), B3LYP/6-31G(d,p), and PM3] were performed to take advantage of ONIOM's layering strategy analysis. The obtained results clearly indicate that the Y181C mutation reduces the binding affinity and stability of the inhibitor by approximately 8-9 kcal/mol as obtained from different combined MO:MO methods. Analyses regarding the energetic components of the interaction and deformation energies for 8-Cl TIBO inhibitor upon binding were also examined extensively. Additional calculations involving the interaction energies between 8-Cl TIBO with individual residues surrounding the binding pocket were performed at MP2/6-31G(d,p) and B3LYP/6-31G(d,p) levels of theory to gain more insight into the energetic differences of wild-type and Y181C mutant type at the atomistic level. © 2005 Wiley-Liss, Inc.
Subject(s)
4,5,6,7 tetrahydroimidazo 8 chloro 5 methyl (3 methyl 2 butenyl)imidazo
RNA directed DNA polymerase
RNA directed DNA polymerase inhibitor
Unclassified drug
Analytic method
Article
Binding affinity
Calculation
Comparative study
Complex formation
Drug binding site
Drug protein binding
Energy
Human immunodeficiency virus 1
Molecular stability
Mutation
Nonhuman
Priority journal
Quantum chemistry
Wild type
Amino Acid Substitution
Dimerization
HIV-1
Kinetics
Models, Molecular
Polymorphism, Single Nucleotide
Protein Structure, Secondary
Protein Subunits
Quantum Theory
Recombinant Proteins
Reverse Transcriptase Inhibitors
RNA-Directed DNA Polymerase
Thermodynamics
Human immunodeficiency virus
Human immunodeficiency virus 1
RNA directed DNA polymerase
RNA directed DNA polymerase inhibitor
Unclassified drug
Analytic method
Article
Binding affinity
Calculation
Comparative study
Complex formation
Drug binding site
Drug protein binding
Energy
Human immunodeficiency virus 1
Molecular stability
Mutation
Nonhuman
Priority journal
Quantum chemistry
Wild type
Amino Acid Substitution
Dimerization
HIV-1
Kinetics
Models, Molecular
Polymorphism, Single Nucleotide
Protein Structure, Secondary
Protein Subunits
Quantum Theory
Recombinant Proteins
Reverse Transcriptase Inhibitors
RNA-Directed DNA Polymerase
Thermodynamics
Human immunodeficiency virus
Human immunodeficiency virus 1
